A phase IV study is a post-marketing study involving approved indications for use.
This type of study is conducted to:
- Improving drug dosing regimens;
- Obtaining information about drug interactions with food or other medications;
- Comparative analysis with other standard therapy regimens;
- Study of drug use in certain age groups or patients in special groups;
- Impact of long-term effects of the drug on survival (decreased or increased mortality rates), etc.
The X7 Research team has extensive experience in conducting post-marketing studies in Russia, EAEU, CIS, EU. We work by the most current legislative requirements in the field of drug circulation.